Across TCGA pan-cancer cohorts, UPK1A Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated UPK1A data layer compared with 18 for mass-spec protein and 3 for mass-spec protein.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher UPK1A Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated UPK1A expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.
COAD, LUAD, and UCEC are the cancer types where UPK1A Mutation most reproducibly stratifies survival.